Article
Anti-Cancer Outcome of Glucocorticoid Receptor Transrepression by Synephrine Derivatives
2025-10-24
Abstract excerpt
<h4>Background: </h4> /Objectives: Glucocorticoids (GCs) present effective anti-cancer drugs for the treatment of hematological malignancies but their clinical use is limited due to their multiple adverse effects. Selective glucocorticoid receptor agonists/modulators (SEGRAMs) modify glucocorticoid receptor (GR) function shifting it towards therapeutically important transrepression and, therefore, could be safer a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 54003f0c-0714-520d-a5e6-fd9e8fd13371
- DOI
- 10.20944/preprints202510.1879.v1
